Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/228659
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments |
Autor: | Çubuk, Cankut; Can, Fatma E.; Peña-Chilet, María CSIC ORCID; Dopazo, Joaquín CSIC ORCID | Palabras clave: | Mechanistic models Gene expression Signaling pathways Signal transduction Cancer therapy Drug mechanism of action Gender bias |
Fecha de publicación: | 29-jun-2020 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Cells 9(7): 1579 (2020) | Resumen: | Despite the existence of differences in gene expression across numerous genes between males and females having been known for a long time, these have been mostly ignored in many studies, including drug development and its therapeutic use. In fact, the consequences of such differences over the disease mechanisms or the drug action mechanisms are completely unknown. Here we applied mechanistic mathematical models of signaling activity to reveal the ultimate functional consequences that gender-specific gene expression activities have over cell functionality and fate. Moreover, we also used the mechanistic modeling framework to simulate the drug interventions and unravel how drug action mechanisms are affected by gender-specific differential gene expression. Interestingly, some cancers have many biological processes significantly affected by these gender-specific differences (e.g., bladder or head and neck carcinomas), while others (e.g., glioblastoma or rectum cancer) are almost insensitive to them. We found that many of these gender-specific differences affect cancer-specific pathways or in physiological signaling pathways, also involved in cancer origin and development. Finally, mechanistic models have the potential to be used for finding alternative therapeutic interventions on the pathways targeted by the drug, which lead to similar results compensating the downstream consequences of gender-specific differences in gene expression. | Descripción: | This article belongs to the Special Issue Targeting Signal Transduction Pathways and Non-coding RNAs as Potential Therapy in Cancer and Aging. | Versión del editor: | http://doi.org/10.3390/cells9071579 | URI: | http://hdl.handle.net/10261/228659 | DOI: | 10.3390/cells9071579 | Identificadores: | doi: 10.3390/cells9071579 e-issn: 2073-4409 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Gender-Specific_Gene.pdf | 3,55 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
57
checked on 28-abr-2024
Download(s)
130
checked on 28-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.